Federal research funding cuts pose an “existential threat” to academic medicine that will have repercussions for patient care in the US, according to a new report from the Association of ...

A research paper from Apple published on June 6 stated that although large reasoning models (LRMs) showed improved performance on benchmarks, they struggled with accuracy when the problems became ...

Trump Administration's Health Report Leaves Researchers Stumped, Concerned Robert F Kennedy Jr, who is the person in-charge of outlining America's health policy and outlook, is an intensely ...

Health and Human Services Secretary Robert F. Kennedy Jr.'s MAHA Report featured several seemingly fake studies and incorrect attributions.

Their research findings and creative works are presented at international conferences, local symposia, and community events. From scholarly lectures to TED-style talks, from academic posters to ...

Aga, SUNY Distinguished Professor and Henry M. Woodburn Chair in the Department of Chemistry, hopes to see even greater participation in next spring’s RENEW poster session and other activities of the ...

WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

TORONTO & PHILADELPHIA-- (BUSINESS WIRE)-- #41BB -- Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for ...

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...

If someone picks up a newspaper in China, there's a good chance it contains some government propaganda masquerading as news, according to a new study co-led by a University of Oregon expert.

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...